Coding and non-coding DNA
Genome-wide sequence data provide context beyond protein-coding regions.
Genome-wide sequencing of coding and non-coding DNA, with broader variant analysis and individual or family-based interpretation options.
Understanding the test
Whole genome sequencing examines coding and non-coding DNA to support investigation of inherited conditions. The workflow includes single-nucleotide variants, small insertions and deletions, copy-number and structural analysis, with individual, duo or trio interpretation options. Selected repeat-region and pharmacogenomic analyses may also be relevant to the order. Ask Genomika which findings are validated and reported for your clinical question; genome-wide sequencing does not identify every possible genetic cause.
PCR-free whole-genome next-generation sequencing with clinically directed variant analysis and optional family comparison.
What is included
WGS is genome-wide rather than a fixed gene panel. A static gene count does not describe its reportable scope. Ask about the genes, regions and variant classes relevant to the clinical question.
Genome-wide sequence data provide context beyond protein-coding regions.
Sequence-variant analysis within the selected reportable scope.
Analysis of broader variant classes; reportable sizes and types depend on the assay.
Selected VNTR analysis; detection of a specific disease-causing repeat expansion requires confirmation of assay scope.
Medication-related interpretation can be part of the genome workflow; ask for the specific reportable targets.
Interpretation can use one person’s data or comparisons with one or two family members.
In clinical context
Choosing a test means considering both the genes or regions examined and the types of changes it can detect.
Your next step
We’ll discuss the clinical question and confirm testing arrangements, sample requirements, costs and reporting times.